KOSDAQApparel & Living073190

Duoback

₩1,622 0.00%2026-11-18 close
Market Cap
₩19.4B
Turnover
₩0
Volume
0 shares
Shares out.
12M
PER
—
PBR
0.5×
EPS
-₩306
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Losses narrowing as listing review proceeds

Duoback cut its operating loss to KRW 163 million in Q3 2026 while sales grew, but it was placed under a substantive listing eligibility review, and the exchange decision is due by November 24, 2026.

  1. 1

    Annual sales fell for three straight years from 2023 to 2025, reaching KRW 20.1 billion in 2025, but Q3 2026 sales of KRW 6.73 billion were up 39.3% from a year earlier.

  2. 2

    According to the company's announcement of August 11, 2026, the cost of sales ratio for H1 2026 fell to 68.9% from 77.9% a year earlier, which it attributed to bringing production processes in-house.

  3. 3

    The exchange placed Duoback under a substantive listing eligibility review on October 2, 2026, and the company filed an improvement plan on October 27. The exchange is due to decide between delisting and an improvement period by November 24, 2026.

  4. 4

    An extraordinary shareholder meeting on October 20, 2026 elected Jeong Young-ah as a director, and she then became CEO following the death of former CEO Jeong Kwan-young. The change in largest shareholder was also completed.

  5. 5

    Total equity at the end of 2025 was KRW 34.3 billion and the debt ratio was 52.1%. Operating cash flow, however, was -KRW 2.35 billion in 2025, a wider deficit than the -KRW 1.13 billion recorded in 2022.

02

Business structure

Duoback designs, manufactures and sells ergonomic chairs built to fit the user's body and support an upright posture. Its core is functional chairs, and it widens its lineup by price tier under separate brands.

The premium brand ERGOBACK's D300, launched in May 2026, reached KRW 400 million in cumulative funding on the crowdfunding platform Wadiz, according to the company. The value-oriented T-Chair series' first model, T-Zero, ranked among the top five monthly sellers on the company's own brand store.

Through its IoT-based smart chair line, the company is also pursuing public procurement demand from government offices and schools, and says procurement sales are growing.

Its chair-centered lineup is expanding into desks and related furniture under its home-office brand Light Office, aiming for a total home-office solution. Overseas, it sells in Northern Europe including Sweden, Norway, Finland, Denmark and Estonia, and is pursuing entry into the Czech Republic and the Netherlands.

In its Q1 2026 filing, domestic sales were KRW 5.82 billion and export sales were KRW 445 million, so the domestic market accounts for most revenue. In home office, Fursys Group's DESKER moved first, and it passed KRW 100 billion in revenue in 2024. The company also tests new products through online channels and crowdfunding before wider launch.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩4.8B-₩800M−16.1%
2025Q4₩5.3B-₩800M−15.0%
2026Q1₩6.3B-₩200M−3.7%
2026Q2₩5.8B-₩700M−11.3%
2026Q3₩6.7B-₩200M−2.4%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩31.6B-₩4.2B-₩3.7B−13.4%−17.9%31.9%
2023₩23.7B-₩3.9B-₩3.8B−16.6%−23.1%51.0%
2024₩23.1B-₩3.4B-₩3.6B−14.6%−27.3%75.2%
2025₩20.1B-₩3B-₩4.6B−15.0%−13.4%52.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-14

04

Earnings analysis

Annual sales went from KRW 31.6 billion in 2022 to KRW 23.7 billion in 2023 (down 24.8% year on year), KRW 23.1 billion in 2024 (down 2.7%), and KRW 20.1 billion in 2025 (down 13.0%). Sales declined for three consecutive years from 2023 to 2025, and 2022 was the largest year in the 2022 to 2025 period.

The operating loss narrowed each year, from KRW 4.22 billion in 2022 to KRW 3.95 billion in 2023, KRW 3.37 billion in 2024 and KRW 3.02 billion in 2025, but the company has posted an operating loss for four consecutive years from 2022 through 2025.

The operating margin stayed between roughly -13% and -16%, at -13.4% in 2022, -16.6% in 2023, -14.6% in 2024 and -15.0% in 2025. Losses shrank in absolute terms as sales fell, but this did not translate into a better margin.

Net loss attributable to controlling shareholders widened from KRW 3.7 billion in 2022 and KRW 3.77 billion in 2023, through KRW 3.56 billion in 2024, to KRW 4.58 billion in 2025.

In 2025 the loss attributable to controlling shareholders exceeded the operating loss of KRW 3.02 billion, which points to a larger impact from non-operating items.

On a quarterly basis, sales rose from KRW 4.83 billion in Q3 2025 to KRW 5.31 billion in Q4 2025 (up 10.0% from the prior quarter) and KRW 6.26 billion in Q1 2026 (up 17.9%), before dipping to KRW 5.78 billion in Q2 2026 (down 7.7%) and rebounding to KRW 6.73 billion in Q3 2026 (up 16.4%).

The operating loss was KRW 234 million in Q1 2026, KRW 652 million in Q2 and KRW 163 million in Q3, the smallest of the last five quarters.

In Q4 2025, however, the loss attributable to controlling shareholders reached KRW 2.31 billion against an operating loss of KRW 796 million, showing how volatile quarterly non-operating items were. The loss attributable to controlling shareholders over the last four quarters totaled KRW 3.39 billion.

Operating cash flow deficits widened from -KRW 1.13 billion in 2022 to -KRW 2.35 billion in 2025. According to the company, H1 2026 sales reached KRW 12.04 billion, up 20.9%, and the operating loss was KRW 890 million, a 38.7% reduction in the deficit.

05

Industry analysis

Duoback specializes in designing and manufacturing ergonomic chairs, with office and home-office furniture as its main end markets. A 2024 brokerage report pointed to weaker office furniture demand that reduced sales for three years after 2021.

Since then, the spread of remote and hybrid work and the 'Resimercial' trend, which blends residential comfort into commercial spaces, have supported home-office demand, and the company is widening its lineup to target it. FnGuide's summary noted that demand for functional chairs grew even amid an economic slowdown.

In home office, however, Fursys Group's DESKER moved first, and competition for share is intense. The chair market is splitting between high-involvement and value-oriented buyers, and Duoback responds with ERGOBACK for the former and T-Chair for the latter.

Overseas, the company exhibited at ORGATEC Tokyo in early June 2026, Asia's major office furniture show, presenting the new BRAVO EDGE model, and it also planned to attend the NeoCon show in the United States. BRAVO EDGE is a value model built on the BRAVO series, which has passed 500,000 cumulative units. Demand recovery signals and price-tier competition pressure coexist in this market.

06

Outlook

The most specific plan the company has disclosed concerns cost structure. According to its August 2026 announcement, it will expand in-house production items and re-examine raw material procurement from the second half of the year.

In May 2026 the company said it would launch the DX2, DX3 and T-Five gaming chair lineup in the second quarter, and it planned new home-office products including a motion desk in June 2026.

In new business, it is pursuing the Duoback Fitting Lounge, which would turn fitting data accumulated through online channels into a personalized chair fitting service and expand to offline stores as operating experience builds. Overseas, it says it will push forward into Japan and North America.

On listing, the exchange's corporate review committee is due to rule by November 24, 2026 on delisting or an improvement period. If an improvement period is granted, the implementation status of the submitted management improvement plan becomes the next checkpoint.

The company's plans are framed around cost and channels rather than numeric targets. On the earnings side, the question is whether the narrowing of the Q3 2026 operating loss to KRW 163 million continues after Q4 2026.

07

Valuation

PER
—
PBR
0.5×
ROE
-15.4%
EPS
-₩306
BPS
₩3,006
Dividend per share
₩0

With losses attributable to controlling shareholders over the last four quarters, the price-to-earnings ratio cannot be calculated. The price-to-book ratio is below 1x, so the share price sits below book value per share.

However, the 2025 asset revaluation, which raised the book value of owned real estate from KRW 7.6 billion to KRW 41.1 billion, is reflected in the balance sheet, so net asset comparisons should be read on a post-revaluation book basis.

The dividend yield is below the industry average, and shareholder returns are limited. In June 2026 the exchange disclosed a warning that market capitalization was below KRW 15 billion, a threshold that can lead to administrative issue designation if it persists for 30 consecutive trading days.

Valuation interpretation depends on the listing review outcome more than on the speed of earnings recovery. The asset-side figures and the earnings-side figures point in different directions, and both need to be read together.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-14

08

Bull factors

Lower cost ratio and sales rebound

According to the company, the cost of sales ratio for H1 2026 fell to 68.9% from 77.9% a year earlier. It credits in-house production and larger output. Sales for the same period rose 20.9% to KRW 12.04 billion, and Q3 2026 sales of KRW 6.73 billion were up 39.3% from a year earlier. The quarterly operating loss narrowed to KRW 163 million in Q3 2026.

Category expansion into home office and overseas

The company has moved beyond chairs into desks and related furniture to build a home-office solution. It sells in five Northern European countries and is pursuing the Czech Republic and the Netherlands. Its June 2026 exhibition at ORGATEC Tokyo started a check on Japan and North America, according to the company. Growth in public procurement sales is cited as evidence of channel diversification.

Financial room and asset revaluation

The debt ratio at the end of 2025 was 52.1%, down from 75.2% at the end of 2024. A news report said the October 2025 asset revaluation raised the book value of owned property to KRW 41.1 billion. A company official said it was not considering fundraising and that it has room to borrow from financial institutions.

09

Bear factors

Sales decline and prolonged losses

Annual sales fell for three consecutive years from 2023 to 2025, down to KRW 20.1 billion in 2025. The operating margin moved lower, from -13.4% in 2022 to -15.0% in 2025.

The company has posted losses for four consecutive years from 2022 through 2025, and the operating cash flow deficit widened to -KRW 2.35 billion in 2025.

Listing review and trading restriction

Trading in the shares was suspended on August 20, 2026, and on October 2 the company was placed under a substantive listing eligibility review. In June 2026 a warning was disclosed about possible administrative issue designation because market capitalization was below KRW 15 billion. A news report said cash and cash equivalents fell to KRW 1.7 billion at the end of Q1 2026.

Governance change and shareholder structure

After the death of former CEO Jeong Kwan-young, the company moved to a CEO led by Jeong Young-ah, and the change in largest shareholder was completed. An investment advisory firm held an 11.37% stake as of May 19, 2026, but a news report said it sold part of its holding on the market.

Management change and shareholder restructuring are happening at the same time, so continuity of direction is the next point to confirm.

10

Risk factors

Listing maintenance review

The exchange's corporate review committee is due to decide between delisting and an improvement period by November 24, 2026. If delisting is decided, the company can file an objection, after which the KOSDAQ Committee makes the final decision. The timing of any resumption of trading depends on the outcome of this process.

Liquidity and fundraising

Cash and cash equivalents fell to KRW 1.7 billion at the end of Q1 2026. A news report said fundraising would become harder if the stock is designated for administrative issues.

The company has pointed to borrowing against its revalued property, but whether it actually raises funds needs to be confirmed through disclosures.

Governance gap and shareholder changes

Following the death of former CEO Jeong Kwan-young, leadership changed, and the company is responding to the listing review with advice from an external law firm. An investment advisory firm holding an 11.37% stake is known to have sold part of its shares on the market. The largest shareholder structure and management direction remain variables alongside the review outcome.

11

What to watch next

  1. By November 24, 2026

    The exchange's corporate review committee decides between delisting and an improvement period. This is the nearest decision point determining whether the listing is maintained and when trading could resume.

  2. After November 24, 2026, if an improvement period is granted

    Check implementation of the management improvement plan submitted by the company and the quarterly sales and operating loss trend. The key question is whether cost ratio gains and loss reduction continue as planned.

  3. By March 31, 2027

    This is the deadline for the 2026 annual business report. Check full-year sales, operating results and the type of audit opinion, which also connects to the listing maintenance review.

  4. By May 15, 2027

    This is the deadline for the Q1 2027 quarterly report. Check whether the cost ratio improvement and operating loss reduction since Q3 2026 hold on a quarterly basis.

12

Overall view

Duoback makes ergonomic chairs. Its revenue declined for three consecutive years from 2023 to 2025, but third-quarter 2026 revenue rose 39.3% year over year to KRW 6.73 billion.

Revenue increased in the first and third quarters of 2026 and fell in the second quarter, and the third-quarter operating loss of KRW 0.16 billion was the smallest of the last five quarters based on disclosed results.

The company cites improvements in its cost of sales ratio and category expansion as the factors behind this trend.

On an annual basis, however, it posted operating losses for four consecutive years from 2022 to 2025, with operating margins staying in the range of -13% to -16%, and net loss attributable to controlling shareholders widened to KRW 4.58 billion in 2025.

On the financial side, total equity of KRW 34.3 billion and a debt-to-equity ratio of 52.1% at the end of 2025 are strengths, but the operating cash flow deficit grew to KRW -2.35 billion in 2025.

On the market side, the October 2026 decision to make the company subject to a substantive listing eligibility review is the biggest variable, and the exchange's deliberation result will be announced by November 24, 2026.

Therefore, the next points to check are the deliberation result, the audit opinion and annual earnings in the 2026 annual report, and whether the cost of sales ratio is maintained in the first-quarter 2027 quarterly report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. comp.fnguide.com
  2. butler.works
  3. asp01.fnguide.com
  4. ssl.pstatic.net
  5. news.nate.com
  6. view.asiae.co.kr
  7. en.edaily.co.kr
  8. edaily.co.kr
  9. markets.hankyung.com
  10. m.thinkpool.com
  11. newspim.com
  12. stockinfo7.com
  13. digitaltoday.co.kr
  14. edaily.co.kr
  15. kr.investing.com
  16. mt.co.kr
  17. newspim.com
  18. topstarnews.net

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis